Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

☰

Ophthotech's Wet AMD Drug Fails to Meet Primary Endpoint in Phase III Study

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks2.jpg" NAME"Ophthotech's Wet AMD Drug Fails to Meet Primary Endpoint in Phase III Study" ALT"Ophthotech's Wet AMD Drug Fails to Meet Primary Endpoint in Phase III Study"August 14, 2017By…

Continue ReadingOphthotech's Wet AMD Drug Fails to Meet Primary Endpoint in Phase III Study

Tiny Virtual Biotech CellAct Forges $250 Million Chemo R&D Pact With Mundipharma

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-deal3.jpg" NAME"Tiny Virtual Biotech CellAct Forges $250 Million Chemo R&D Pact With Mundipharma" ALT"Tiny Virtual Biotech CellAct Forges $250 Million Chemo R&D Pact With Mundipharma"August 14, 2017By Alex Keown,…

Continue ReadingTiny Virtual Biotech CellAct Forges $250 Million Chemo R&D Pact With Mundipharma